logo

Mannkind Corp. (MNKD)



Trade MNKD now with
  Date
  Headline
4/19/2021 6:08:32 AM MannKind, United Therapeutics Reach Milestone In Development Of Tyvaso DPI
3/2/2021 6:36:16 AM MannKind Prices Upsized $200.0 Mln Convertible Senior Notes Offering
3/1/2021 7:14:35 AM MannKind Intends To Offer $150.0 Mln Of Convertible Senior Notes Due 2026
2/25/2021 8:09:42 AM MannKind Q4 Loss/Shr $0.11 Vs Loss $0.07 Last Year
2/24/2021 8:01:34 AM Vertice Launches THYQUIDITY Oral Solution
12/10/2020 8:14:37 AM MannKind Names James Shannon New Chairman Of The Board
7/20/2020 9:23:48 AM MannKind Names Alejandro Galindo Chief Commercial Officer
3/17/2020 9:05:10 AM MannKind Adjusts R&D Resources In Response To COVID-19 Pandemic
2/25/2020 8:16:25 AM MannKind Q4 Loss Per Share $0.07 Vs Loss $0.06 Last Year
1/6/2020 8:15:54 AM MannKind Partner Biomm Receive Written Notice From CMED Approving Proposed Price Of Afrezza In Brazil